Superior Group of CompaniesSGC
Recorded

Superior Group of Companies 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration29 minParticipants8

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, and welcome to the Superior Group of Companies Third Quarter 2026 Conference Call. With us today are Michael Benstock, Chief Executive Officer, and Mike Koempel, President and Chief Financial Officer. In addition, Dominic Leide, President of the company's Contact Centers segment, will join today's Q&A session. As a reminder, this conference call is being recorded. This call may contain forward-looking statements regarding the company's plans, initiatives, and strategies, and the anticipated financial performance of the company, including but not limited to sales and profitability. Such statements are based upon management's current expectations, projections, estimates, and assumptions. Words such as expect, believe, anticipate, think, outlook, hope, and variations of such words and similar expressions identify such forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements.

Operator

Such risks and uncertainties are further disclosed in the company's periodic filings with the Securities and Exchange Commission, including but not limited to the company's most recent annual report on Form 10-K and the quarterly reports on Form 10-Q. Shareholders, potential investors, and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The company does not undertake to update the forward-looking statements, except as required by law. I'll turn the call over to Michael Benstock.

Michael BenstockCEO

Thanks, operator, and thank you for those joining us this morning. Let's dive right into Q3. We generated top-line growth of 5% this quarter, which accelerated from the second quarter's 3% increase. This was driven by continued momentum for both Branded Products and Contact Centers, each of which grew revenues while also generating double-digit EBITDA growth. Our Healthcare Apparel segment continued to execute on the transition that we addressed in our previous earnings call, with new and deeper leadership additions. These additions and strategies will lead us to more focused product and sourcing strategies, which in turn will lead to higher margins and reduced working capital needs. Thanks to the strength of SGC's diversification and stronger underlying profitability, the impact was significantly offset.

Michael BenstockCEO

EPS was down just slightly year-over-year at $0.17, despite the incremental charges related to the strategic repositioning of our Healthcare Apparel business that Mike will discuss in greater detail. During the quarter, we further improved our solid balance sheet, successfully completed a debt refinancing, which places us in a position of strength to execute our capital allocation strategy. To that point, we're pleased to have executed one of our key strategic growth initiatives, which we spoke about on prior calls, with the recently announced acquisition of Select VoiceCom, a Philippine BPO. With this transformational acquisition, our Contact Centers segment, The Office Gurus, expands its global delivery capabilities from nearshore to also offshore across numerous new market channels. This expands our addressable market for services well beyond our prior capabilities.

Michael BenstockCEO

The sequential improvement in our segment results, combined with an expanded offering in the Philippines, sets us up for a stronger platform for growth. This acquisition is expected to be accretive to our earnings in the first quarter of 2027, its first full quarter under the SGC umbrella, and further increase our already solid cash flow. Let's now discuss the quarterly performance of our three business segments. Branded Products, our largest business, drove revenue growth of 8% versus the year-ago quarter. This reflects higher volumes with existing customers as well as new customer additions. Similar to last quarter, we expanded our gross margin partially due to stronger pricing and improved SG&A as a percentage of sales. The result was 31% growth in EBITDA.

Michael BenstockCEO

We are confident in our ability to expand our market share and are excited about the upcoming start of a chief revenue officer, the repositioning of one of our executives to focus on uniform sales under the Branded Products umbrella, as well as the recent hiring of a top executive to lead marketing to further expand our growth strategies in this segment. These three positions are investments that we're making to grow our business well beyond its current state. Within Healthcare Apparel, consistent with the second quarter, new leadership is pursuing a more focused product strategy, which requires streamlining the current product assortment and its related inventory position. This, as well as other market factors, necessitated an inventory write-down during the quarter. As a result, our Healthcare Apparel segment EBITDA was about $3.7 million lower than the prior year period.

Michael BenstockCEO

While the strategic shift has weighed on segment results, we view the transition by new leadership, including the recent hiring of a VP of supply chain, as a necessary step in creating a stronger and more profitable Healthcare Apparel business that will benefit from favorable long-term secular trends. Lastly, our Contact Centers segment grew revenue 7% over the prior year and sequentially improved from the second quarter. While the gross margin rate was flat versus the prior year, it sequentially improved by two full points from the prior quarter, and SG&A as a percentage of revenue improved by two points. The result was a 22% increase in EBITDA. We expect continued growth as we convert a growing pipeline into new business. Wrapping up, we are increasingly optimistic about our business today.

Michael BenstockCEO

While there are plenty of opportunities to make further improvements, particularly related to the turnaround of our Healthcare Apparel segment, the combination of stronger underlying profitability, several critical leadership hires, and our recent acquisition materially improve our capabilities and prospects for growth. With that, Mike will now take us through the financial details and our improved outlook ranges for the year.

Mike KoempelPresident and CFO

Thank you, Michael, and thanks everyone for being with us. We grew our third quarter consolidated revenue by 5% year-over-year to $146 million, which, as Michael noted, surpassed the second quarter growth of 3%. Branded Products led the way with top-line growth of 8% to $92 million, benefiting from higher volumes with existing customers, and Contact Centers grew revenue 7% to $24 million, driven by new customer acquisitions and growth from existing customers. Healthcare Apparel revenue was off just 3% to $31 million due to volume decreases with existing customers, due in part to the change in a customer's financial position. Our gross margin for the third quarter came in at 38%, which was about flat both year-over-year and sequentially, as strength in Branded Products margins was offset by a sharp decline in Healthcare Apparel.

Mike KoempelPresident and CFO

Branded Products gross margin improved by 160 basis points, primarily driven by a favorable shift in the mix of pricing and customers. Healthcare Apparel gross margin was down 580 basis points due to a $4 million incremental inventory write-down in connection with further streamlining the product assortment, partially offset by $1.8 million of tariff refunds. The Contact Centers gross margin was flat compared to the year-ago quarter and up sequentially from the second quarter by 200 basis points. SG&A for the third quarter was also roughly flat as a percentage of sales at 35.5%, with improvements at both our Branded Products and Contact Center segments offset by Healthcare Apparel, primarily due to credit loss charges resulting from the change in a customer's financial position. Moving on to EBITDA, our third quarter result of $6.7 million compares to $7.5 million in the third quarter of 2025.

Mike KoempelPresident and CFO

Strong EBITDA growth in Branded Products and Contact Centers of 31% and 22% respectively was more than offset by a $3.7 million decrease in Healthcare Apparel EBITDA due to the significant inventory and credit loss charges that I previously mentioned. For the third quarter, our net interest expense improved once again to just over $800,000, down from $1.4 million a year earlier. This improvement was driven by a $25 million reduction in average debt outstanding. Turning to net income, we generated $2.6 million in the third quarter, which equated to diluted earnings per share of $0.17, down just slightly versus the prior year, despite the aforementioned charges in Healthcare Apparel.

Mike KoempelPresident and CFO

Moving on to our balance sheet, we ended September with cash and equivalents of $28 million, up from $24 million at prior year end, on top of the significant reduction in average debt outstanding. Our improved financial position was driven by operating cash flow of $31 million year to date, compared to just $1 million in the prior year period. Also, during the third quarter, we amended and extended our $200 million credit facility for another five years, providing flexibility and capacity to support our capital allocation strategy. The strength of our balance sheet, combined with our new credit facility, enables us to pursue growth initiatives across our segments, such as the Contact Centers acquisition of Select VoiceCom, as Michael mentioned earlier.

Mike KoempelPresident and CFO

Lastly, during the third quarter, we paid $2.2 million in dividends, resulting in an attractive dividend yield, and we have approximately $9 million available under our share repurchase authorization to take advantage of opportunistic share repurchases. I will wrap up with our updated full-year outlook, which includes a tightening of our previous ranges, given the continued strong performance of our diversified business and our confidence looking ahead. Our full-year 2026 net sales forecast is a range of $578 million-$585 million, compared to our previous range of $572 million-$585 million, and up from 2025 net sales of $566 million.

Mike KoempelPresident and CFO

We are also tightening our full-year adjusted earnings per diluted share forecast to a range of $0.60-$0.66 from our previous range of $0.54-$0.66, and up from $0.46 in 2025, representing 43% growth at the high end. With that, operator, Michael, Dom, and I would be happy to take questions if you could please open the lines.

Operator

We will now begin the question-and-answer session. To ask a question, you may press star, then one on your touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, please press star, then two. At this time, we will pause momentarily to assemble our roster. The first question today comes from Michael Baker with D.A. Davidson. Please go ahead. Hi.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day